TY - JOUR
T1 - Risk of Noncardiac Surgery After Coronary Drug-Eluting Stent Implantation
AU - Compton, P. Alexander
AU - Zankar, Ahmad A.
AU - Adesanya, Adebola O.
AU - Banerjee, Subhash
AU - Brilakis, Emmanouil S.
N1 - Funding Information:
Dr. Brilakis was supported by the Clark R. Gregg Fund, Harris Methodist Health Foundation, Fort Worth, Texas, and the Veterans Affairs VISN 17 Startup Award, Waco, Texas. Coronary artery disease
PY - 2006/11/1
Y1 - 2006/11/1
N2 - We examined the records of 38 patients who underwent 41 major and 18 minor noncardiac surgeries after successful drug-eluting stent (DES) implantation (57% sirolimus-eluting stents and 43% paclitaxel-eluting stents) at the Dallas Veterans Affairs Medical Center from April 2003 to January 2006. The mean patient age was 62 ± 9 years, and all patients were men. A total of 41 major noncardiac surgeries (34% abdominal, 22% vascular, 17% genitourinary, and 27% other) were performed in 28 patients a median of 260 days after DES implantation. Also, 18 minor noncardiac surgeries (44% skin surgery, 44% injections, and 12% other) were performed in 10 patients a median of 297 days after DES implantation. No major adverse cardiac events or death occurred during or after the 41 major (0%, 95% confidence interval 0% to 9%) and 18 minor noncardiac (0%, 95% confidence interval 0% to 19%) surgeries. In conclusion, although our data were limited by the small sample size, they suggest a low risk of major cardiac complications in patients undergoing noncardiac surgery after coronary DES implantation.
AB - We examined the records of 38 patients who underwent 41 major and 18 minor noncardiac surgeries after successful drug-eluting stent (DES) implantation (57% sirolimus-eluting stents and 43% paclitaxel-eluting stents) at the Dallas Veterans Affairs Medical Center from April 2003 to January 2006. The mean patient age was 62 ± 9 years, and all patients were men. A total of 41 major noncardiac surgeries (34% abdominal, 22% vascular, 17% genitourinary, and 27% other) were performed in 28 patients a median of 260 days after DES implantation. Also, 18 minor noncardiac surgeries (44% skin surgery, 44% injections, and 12% other) were performed in 10 patients a median of 297 days after DES implantation. No major adverse cardiac events or death occurred during or after the 41 major (0%, 95% confidence interval 0% to 9%) and 18 minor noncardiac (0%, 95% confidence interval 0% to 19%) surgeries. In conclusion, although our data were limited by the small sample size, they suggest a low risk of major cardiac complications in patients undergoing noncardiac surgery after coronary DES implantation.
UR - http://www.scopus.com/inward/record.url?scp=33750084402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33750084402&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2006.05.050
DO - 10.1016/j.amjcard.2006.05.050
M3 - Article
C2 - 17056330
AN - SCOPUS:33750084402
SN - 0002-9149
VL - 98
SP - 1212
EP - 1213
JO - American Journal of Cardiology
JF - American Journal of Cardiology
IS - 9
ER -